search
Back to results

Conscious Sedation for Cataract Operations Under Topical Anaesthesia

Primary Purpose

Conscious Sedation

Status
Completed
Phase
Phase 2
Locations
Egypt
Study Type
Interventional
Intervention
Nalbuphine
Propofol
Dexmedetomidine
Benoxinate Hydrochloride 0.4% Eye Drops
Sponsored by
Menoufia University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Conscious Sedation

Eligibility Criteria

20 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Both genders,
  • 20 and 65 years,
  • American Society of Anesthesiologists (ASA) physical status I and II,
  • Scheduled for cataract extraction surgery under topical anaesthesia.

Exclusion Criteria:

  • Known allergy to local anaesthetics,
  • Allergy to study drugs,
  • Second or third-degree heart block,
  • Alcohol or drug abuse
  • Morbid obesity, pregnant and lactating females,
  • Patients with severe cardiac, renal and hepatic disorders.

Sites / Locations

  • Faculty of Medicine

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Group P

Droup D

Arm Description

nalbuphine/propofol group

Nalbuphine/dexmedetomidine group

Outcomes

Primary Outcome Measures

Sedation score
The degree of sedation assessed by Ramsay sedation score(1 = anxious, agitated, restless;2 = cooperative, oriented, tranquil; 3 = responds to commands only; 4 = brisk response to light glabellar tap or loud noise; 5 = sluggish response to light glabellar tap or loud noise; 6 = no response), score of (1) means inadequate sedation. Score (2 to 4) indicates acceptable sedation. Score (5) or (6) excessive sedation.

Secondary Outcome Measures

Heart rate
Heart rate in beats/minutes
Mean arterial blood pressure
Mean arterial blood pressure in mmHg
Oxygen saturation
Arterial oxygen saturation as a percentage of the total haemoglobin
Analgesia
Measured by Numerical Pain Rating scale where the patient verbally rates pain from 0 "no pain" to 10 "worst imaginable pain"

Full Information

First Posted
April 26, 2019
Last Updated
January 7, 2021
Sponsor
Menoufia University
search

1. Study Identification

Unique Protocol Identification Number
NCT03933280
Brief Title
Conscious Sedation for Cataract Operations Under Topical Anaesthesia
Official Title
Nalbuphine/Dexmedetomidine Versus Nalbuphine/Propofol Conscious Sedation for Cataract Extraction Under Topical Anaesthesia: A Double-Blind Randomized Trial
Study Type
Interventional

2. Study Status

Record Verification Date
January 2021
Overall Recruitment Status
Completed
Study Start Date
July 1, 2019 (Actual)
Primary Completion Date
December 1, 2020 (Actual)
Study Completion Date
January 1, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Menoufia University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Topical anaesthesia of the eye for ophthalmologic procedures avoids pain and discomfort of local anaesthetic injection in the peribulbar or retrobulbar block so that patient comfortability is achieved. Sedation during topical anaesthesia of the eye is mostly required to achieve anxiolysis, amnesia and keeping the patient calm all through the procedure. In the present study, the investigators will investigate the effect of nalbuphine/dexmedetomidine versus nalbuphine/propofol on the sedation as a primary outcome, intra-operative, postoperative analgesia, vital signs, patient and surgeon satisfaction and side effects as secondary outcomes
Detailed Description
In both groups, the patients will receive i.v. nalbuphine 50 μg/kg. Patients in group D, will receive an i.v. loading dose of dexmedetomidine 1 μg/kg over 10 min followed by a maintenance infusion of 0.5 μg/kg/h. Patients in group P, will receive a bolus i.v. dose of propofol 0.5 mg/kg followed by an infusion started at 0.025 mg/kg/min .If sedation score was <3, rescue sedation with boluses of midazolam 0.01 mg/kg will be given. If the patient complained of pain (Numerical verbal pain rating scale ≥3) during the surgery, i.v. fentanyl 50 μg will be given as an intra-operative rescue analgesic and the surgeon will be instructed to use additional topical local anaesthetic eye drops if appropriate. After the completion of surgery, all infusions will be stopped, and the patients will be shifted to the postanaesthetic care unit (PACU) to be monitored for 2 hours before discharge.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Conscious Sedation

7. Study Design

Primary Purpose
Other
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Masking Description
An independent anaesthesiologist not involved in the study will open the randomisation envelope just before the premedication and will prepare the appropriate drug-filled syringes according to the code and will not take part in the management and observations. (Syringes and infusion lines will be concealed by wrapping with an aluminium foil). A blinded investigator that will not be involved in the anaesthetic management of the patients, will collect the intra-operative and postoperative data.
Allocation
Randomized
Enrollment
100 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Group P
Arm Type
Active Comparator
Arm Description
nalbuphine/propofol group
Arm Title
Droup D
Arm Type
Active Comparator
Arm Description
Nalbuphine/dexmedetomidine group
Intervention Type
Drug
Intervention Name(s)
Nalbuphine
Other Intervention Name(s)
Nalbuphine bolus
Intervention Description
i.v. nalbuphine bolus of 50 μg/kg.
Intervention Type
Drug
Intervention Name(s)
Propofol
Other Intervention Name(s)
propofol infusion
Intervention Description
A bolus i.v. dose of propofol 0.5 mg/kg followed by an infusion of 0.025 mg/kg/min
Intervention Type
Drug
Intervention Name(s)
Dexmedetomidine
Other Intervention Name(s)
Dexmedetomidine infusion
Intervention Description
i.v. loading dose of dexmedetomidine 1 μg/kg over 10 min followed by a maintenance infusion of 0.5 μg/kg/h.
Intervention Type
Drug
Intervention Name(s)
Benoxinate Hydrochloride 0.4% Eye Drops
Other Intervention Name(s)
Topical anaesthesia of the eye
Intervention Description
Benoxinate hydrochloride 0.4% eye drops instilled twice, 5 minutes apart.
Primary Outcome Measure Information:
Title
Sedation score
Description
The degree of sedation assessed by Ramsay sedation score(1 = anxious, agitated, restless;2 = cooperative, oriented, tranquil; 3 = responds to commands only; 4 = brisk response to light glabellar tap or loud noise; 5 = sluggish response to light glabellar tap or loud noise; 6 = no response), score of (1) means inadequate sedation. Score (2 to 4) indicates acceptable sedation. Score (5) or (6) excessive sedation.
Time Frame
perioperative
Secondary Outcome Measure Information:
Title
Heart rate
Description
Heart rate in beats/minutes
Time Frame
perioperative
Title
Mean arterial blood pressure
Description
Mean arterial blood pressure in mmHg
Time Frame
perioperative
Title
Oxygen saturation
Description
Arterial oxygen saturation as a percentage of the total haemoglobin
Time Frame
perioperative
Title
Analgesia
Description
Measured by Numerical Pain Rating scale where the patient verbally rates pain from 0 "no pain" to 10 "worst imaginable pain"
Time Frame
perioperative

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Both genders, 20 and 65 years, American Society of Anesthesiologists (ASA) physical status I and II, Scheduled for cataract extraction surgery under topical anaesthesia. Exclusion Criteria: Known allergy to local anaesthetics, Allergy to study drugs, Second or third-degree heart block, Alcohol or drug abuse Morbid obesity, pregnant and lactating females, Patients with severe cardiac, renal and hepatic disorders.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Abd-Elazeem A Elbakry, MD
Organizational Affiliation
Associate professor
Official's Role
Principal Investigator
Facility Information:
Facility Name
Faculty of Medicine
City
Cairo
State/Province
Shebin El-kom
ZIP/Postal Code
32511
Country
Egypt

12. IPD Sharing Statement

Learn more about this trial

Conscious Sedation for Cataract Operations Under Topical Anaesthesia

We'll reach out to this number within 24 hrs